Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Livermore

Showing results (651-660 of 807) with videos related to

Pageof 81
Sort By:
Nature Biotechnology|June 26, 2019
Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infectionThemoula Charalampous, Gemma L Kay, Hollian Richardson, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2013
Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpointsAjay Sudan, Joanne Livermore, Susan J Howard, et al.
Journal of Neuro-Oncology|February 9, 2023
Do animal models of brain tumors replicate human peritumoral edema? a systematic literature searchMoritz W J Schramm, Stuart Currie, Ming-Te Lee, et al.
The American Journal of Psychiatry|February 17, 1998
Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levelsK Y Little, D P McLaughlin, L Zhang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2009
A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patientsRonen Ben-Ami, Jesús Rodríguez-Baño, Hande Arslan, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2009
2-Amino-5-aryl-pyridines as selective CB2 agonists: synthesis and investigation of structure-activity relationshipsRobert J Gleave, Paul J Beswick, Andrew J Brown, et al.
Journal of Medicinal Chemistry|October 28, 2005
2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokineticsAlan D Borthwick, Dave E Davies, Anne M Exall, et al.
International Journal of Antimicrobial Agents|February 9, 2025
Ceftriaxone population pharmacokinetics in plasma and cerebrospinal fluid of neurocritical care patientsNilesh Kumta, Aaron J Heffernan, Xin Liu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2012
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in EuropeR Cantón, M Akóva, Y Carmeli, et al.
The Journal of Infectious Diseases|April 20, 2013
Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patientsLucy O'Connor, Joanne Livermore, Andrew D Sharp, et al.
Pageof 81

Showing results (651-660 of 807) with videos related to

Sort By:
Pageof 81
Nature Biotechnology|June 26, 2019
Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infectionThemoula Charalampous, Gemma L Kay, Hollian Richardson, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2013
Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpointsAjay Sudan, Joanne Livermore, Susan J Howard, et al.
Journal of Neuro-Oncology|February 9, 2023
Do animal models of brain tumors replicate human peritumoral edema? a systematic literature searchMoritz W J Schramm, Stuart Currie, Ming-Te Lee, et al.
The American Journal of Psychiatry|February 17, 1998
Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levelsK Y Little, D P McLaughlin, L Zhang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 23, 2009
A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patientsRonen Ben-Ami, Jesús Rodríguez-Baño, Hande Arslan, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2009
2-Amino-5-aryl-pyridines as selective CB2 agonists: synthesis and investigation of structure-activity relationshipsRobert J Gleave, Paul J Beswick, Andrew J Brown, et al.
Journal of Medicinal Chemistry|October 28, 2005
2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokineticsAlan D Borthwick, Dave E Davies, Anne M Exall, et al.
International Journal of Antimicrobial Agents|February 9, 2025
Ceftriaxone population pharmacokinetics in plasma and cerebrospinal fluid of neurocritical care patientsNilesh Kumta, Aaron J Heffernan, Xin Liu, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2012
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in EuropeR Cantón, M Akóva, Y Carmeli, et al.
The Journal of Infectious Diseases|April 20, 2013
Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patientsLucy O'Connor, Joanne Livermore, Andrew D Sharp, et al.
Pageof 81